Anti-GD2 antibody-containing immunotherapy post-consolidation therapy for people with high-risk neuroblastoma treated with autologous hematopoietic stem cell transplantation

Frank Peinemann, Elvira C. van Dalen, Frank Berthold

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

6 Citaten (Scopus)

Samenvatting

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess whether people with high-risk neuroblastoma have an additional benefit in terms of survival and tumor response of anti-GD2 antibody added to the post-consolidation therapy after high-dose chemotherapy and autologous hematopoietic stem cell transplantation as compared to placebo or no therapy, and whether anti-GD2 antibody has adverse events and impact on quality of life.

Originele taal-2Engels
ArtikelnummerCD012442
TijdschriftCochrane Database of Systematic Reviews
Volume2016
Nummer van het tijdschrift11
DOI's
StatusGepubliceerd - 22 nov. 2016
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Anti-GD2 antibody-containing immunotherapy post-consolidation therapy for people with high-risk neuroblastoma treated with autologous hematopoietic stem cell transplantation'. Samen vormen ze een unieke vingerafdruk.

Citeer dit